fbpx
February 5, 2021

FDA Curbs Use of COVID-19 Convalescent Plasma, Citing New Data FDA Curbs Use of COVID-19 Convalescent Plasma, Citing New Data

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) has revised its emergency use […]
February 5, 2021

Tofacitinib Linked to Risk for Cardiac Events, Cancer, FDA Warns Tofacitinib Linked to Risk for Cardiac Events, Cancer, FDA Warns

The Food and Drug Administration has alerted the public to an increased risk of serious heart-related problems and cancer risk associated with the Janus kinase inhibitor […]
February 4, 2021

FDA Grants MET Inhibitor Tepotinib Accelerated Approval for NSCLC FDA Grants MET Inhibitor Tepotinib Accelerated Approval for NSCLC

The Food and Drug Administration has granted accelerated approval for tepotinib (TEPMETKO) for the treatment of adults with metastatic non–small cell lung cancer (NSCLC) harboring MET […]
February 3, 2021

RAP Device Cleared for Short-term Improvement in Cellulite RAP Device Cleared for Short-term Improvement in Cellulite

Soliton’s Rapid Acoustic Pulse (RAP) device, which was cleared for tattoo removal in 2019, has received FDA clearance for short-term improvement in the appearance of cellulite. […]
February 3, 2021

FDA Recalls Subcutaneous-ICD Leads Due to Fracture Risk FDA Recalls Subcutaneous-ICD Leads Due to Fracture Risk

The US Food and Drug Administration (FDA) has issued a Class I recall of the electrode component of the EMBLEM S-ICD (Boston Scientific), the iconic subcutaneous […]
February 1, 2021

EU Panel Backs Icosapent Ethyl for CV Event Reduction EU Panel Backs Icosapent Ethyl for CV Event Reduction

The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of icosapent ethyl to reduce the risk for cardiovascular (CV) […]
January 28, 2021

FDA OKs First Injectable Complete Drug Regimen for HIV FDA OKs First Injectable Complete Drug Regimen for HIV

The US Food and Drug Administration (FDA) has approved Cabenuva, an injectable formulation of cabotegravir (Vocabria) and rilpivirine (Edurant), for adults living with HIV-1 infection. Cabenuva […]
January 27, 2021

FDA Approves Voclosporin for Lupus Nephritis FDA Approves Voclosporin for Lupus Nephritis

The Food and Drug Administration has approved voclosporin (Lupkynis) for the treatment of lupus nephritis, according to a Jan. 22 press release from manufacturer Aurinia Pharmaceuticals. […]
January 26, 2021

USMLE Stuns Again: Clinical Skills Test Permanently Ended USMLE Stuns Again: Clinical Skills Test Permanently Ended

The Step 2 Clinical Skills (CS) test for medical school students and graduates has been permanently canceled, cosponsors of the US Medical Licensing Examination (USMLE) announced […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0